2022 Q1 Form 20-F Financial Statement

#000106299322018015 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2022 2021 Q1
Revenue $6.700M $32.98M $9.146M
YoY Change -26.74% -1.44% -3.85%
Cost Of Revenue $2.553M $14.17M $3.622M
YoY Change -29.52% -8.08% -42.93%
Gross Profit $4.147M $18.81M $5.524M
YoY Change -24.92% 4.23% 74.53%
Gross Profit Margin 61.9% 57.03% 60.39%
Selling, General & Admin $1.560M $9.055M $2.045M
YoY Change -23.74% 2.81% -15.22%
% of Gross Profit 37.61% 48.14% 37.03%
Research & Development $26.78K
YoY Change 69.14%
% of Gross Profit 0.14%
Depreciation & Amortization $431.6K $1.818M $782.0K
YoY Change -44.82% -19.92% -76.04%
% of Gross Profit 10.41% 9.67% 14.16%
Operating Expenses $1.714M $9.082M $2.504M
YoY Change -31.52% 2.93% -14.4%
Operating Profit $2.433M $9.755M $3.020M
YoY Change -19.44% 5.57% 1157.0%
Interest Expense $112.6K $1.077M -$7.994M
YoY Change -101.41% -72.6% -363.92%
% of Operating Profit 4.63% 11.04% -264.7%
Other Income/Expense, Net -$61.63K $108.5K $18.89K
YoY Change -426.26% -61.16% -97.92%
Pretax Income $2.159M $17.13M -$5.664M
YoY Change -138.12% -1148.83% -71.3%
Income Tax $948.2K $3.973M $917.8K
% Of Pretax Income 43.91% 23.19%
Net Earnings -$1.032M $10.92M -$6.582M
YoY Change -84.32% -239.42% -69.11%
Net Earnings / Revenue -15.4% 33.1% -71.96%
Basic Earnings Per Share $0.09
Diluted Earnings Per Share -$8.681K $0.09 -$51.63K
COMMON SHARES
Basic Shares Outstanding 120.0M 118.3M
Diluted Shares Outstanding 121.1M

Balance Sheet

Concept 2022 Q1 2022 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.068M $3.068M $6.237M
YoY Change -50.81% -50.81% 102.74%
Cash & Equivalents $3.068M $6.237M
Short-Term Investments
Other Short-Term Assets $2.952M $2.952M $2.375M
YoY Change 24.3% 24.3% 336.92%
Inventory $4.054M $4.054M $2.693M
Prepaid Expenses
Receivables $198.5K $198.5K $101.2K
Other Receivables $11.94K $11.94K $27.99K
Total Short-Term Assets $10.28M $10.28M $11.32M
YoY Change -9.12% -33.99% -2.97%
LONG-TERM ASSETS
Property, Plant & Equipment $4.870M $13.75M $2.749M
YoY Change 77.16% 0.46% -67.64%
Goodwill $28.54M $28.54M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $58.04K $58.04K $47.74K
YoY Change 21.58% 21.58% 3.54%
Total Long-Term Assets $51.57M $51.57M $55.50M
YoY Change -7.09% -3.12% 11.48%
TOTAL ASSETS
Total Short-Term Assets $10.28M $10.28M $11.32M
Total Long-Term Assets $51.57M $51.57M $55.50M
Total Assets $61.85M $61.85M $66.82M
YoY Change -7.43% -10.11% 8.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.403M $1.403M $1.383M
YoY Change 1.45% 1.45% 21.6%
Accrued Expenses $1.041M $1.432M $1.183M
YoY Change -12.03% 10.28% -49.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.361M $7.361M $9.036M
YoY Change -18.54% -18.54% -70.44%
Total Short-Term Liabilities $14.73M $14.73M $15.23M
YoY Change -3.3% -6.34% -60.56%
LONG-TERM LIABILITIES
Long-Term Debt $2.027M $2.027M $18.26M
YoY Change -88.9% -88.9% 231.97%
Other Long-Term Liabilities $10.12M $10.12M $9.486M
YoY Change 6.63% 6.63% 152.81%
Total Long-Term Liabilities $12.14M $12.14M $27.75M
YoY Change -56.24% -56.24% 199.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.73M $14.73M $15.23M
Total Long-Term Liabilities $12.14M $12.14M $27.75M
Total Liabilities $26.87M $26.87M $43.56M
YoY Change -38.32% -38.19% -9.0%
SHAREHOLDERS EQUITY
Retained Earnings -$68.51M -$79.43M
YoY Change -13.74%
Common Stock $105.2M $103.6M
YoY Change 1.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.98M $34.98M $23.26M
YoY Change
Total Liabilities & Shareholders Equity $61.85M $61.85M $66.82M
YoY Change -7.43% -10.11% 8.74%

Cashflow Statement

Concept 2022 Q1 2022 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.032M $10.92M -$6.582M
YoY Change -84.32% -239.42% -69.11%
Depreciation, Depletion And Amortization $431.6K $1.818M $782.0K
YoY Change -44.82% -19.92% -76.04%
Cash From Operating Activities $2.069M $6.836M $1.191M
YoY Change 73.73% -31.11% -48.83%
INVESTING ACTIVITIES
Capital Expenditures -$108.5K $2.562M -$158.5K
YoY Change -31.58% 1024.92% 78.7%
Acquisitions
YoY Change
Other Investing Activities -$31.65K $1.168M -$746.3K
YoY Change -95.76% -233.33% -118.19%
Cash From Investing Activities -$140.1K -$1.394M -$904.8K
YoY Change -84.51% 26.26% -122.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.671M -7.845M 2.660M
YoY Change -162.83% 37.74% -147.65%
NET CHANGE
Cash From Operating Activities 2.069M 6.836M 1.191M
Cash From Investing Activities -140.1K -1.394M -904.8K
Cash From Financing Activities -1.671M -7.845M 2.660M
Net Change In Cash 257.2K -$3.169M 2.946M
YoY Change -91.27% -200.27% 288.08%
FREE CASH FLOW
Cash From Operating Activities $2.069M $6.836M $1.191M
Capital Expenditures -$108.5K $2.562M -$158.5K
Free Cash Flow $2.177M $4.274M $1.349M
YoY Change 61.36% -55.92% -44.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Name
AuditorName
Baker Tilly US, LLP
CY2022 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2022 dei Auditor Firm
AuditorFirmId
23
CY2022Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
2178145 usd
CY2021Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
1492826 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
10284474 usd
CY2021Q1 us-gaap Assets Current
AssetsCurrent
11316709 usd
CY2022Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0 usd
CY2021Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
3313334 usd
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1281442 usd
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3658162 usd
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3378299 usd
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
874379 usd
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
628171 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14728550 usd
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
15230733 usd
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
9759127 usd
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 usd
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
1132658 usd
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117057860
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
117057860
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
103636830 usd
CY2022 us-gaap Other Operating Income
OtherOperatingIncome
108470 usd
CY2021 us-gaap Other Operating Income
OtherOperatingIncome
35275 usd
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
13610017 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2582903 usd
CY2021 cxxif Stock Issued During Period Value Repayment Of Convertible Promissory Note
StockIssuedDuringPeriodValueRepaymentOfConvertiblePromissoryNote
38415 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
98950 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
12758473 usd
CY2021 cxxif Stock Issued During Period Value Purchase Commitment
StockIssuedDuringPeriodValuePurchaseCommitment
0 usd
CY2021 cxxif Stock Issued During Period Value To Vendors For Partial Settlement
StockIssuedDuringPeriodValueToVendorsForPartialSettlement
0 usd
CY2021 cxxif Standby Warrants Issued
StandbyWarrantsIssued
2116192 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
494435 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8443237 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
23256148 usd
CY2022 cxxif Stock Issued During Period Value To Vendors For Partial Settlement
StockIssuedDuringPeriodValueToVendorsForPartialSettlement
0 usd
CY2022 cxxif Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
533326 usd
CY2022 cxxif Stock Issued During Period Value Guaranteed Warrants
StockIssuedDuringPeriodValueGuaranteedWarrants
0 usd
CY2022 cxxif Stock Issued During Period Value Settlement Of Earn Out Shares
StockIssuedDuringPeriodValueSettlementOfEarnOutShares
677939 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
366469 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10149310 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
34983192 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
135564 usd
CY2022 us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
0 usd
CY2021 us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
130000 usd
CY2022 cxxif Payment For Contingent Consideration Liability One Investing Activities
PaymentForContingentConsiderationLiabilityOneInvestingActivities
0 usd
CY2021 cxxif Payment For Contingent Consideration Liability One Investing Activities
PaymentForContingentConsiderationLiabilityOneInvestingActivities
846256 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
533326 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
98950 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5688442 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-766841 usd
CY2022 cxxif Right Of Use Asset Additions Resulting From Lease Renewals
RightOfUseAssetAdditionsResultingFromLeaseRenewals
0 usd
CY2021 cxxif Right Of Use Asset Additions Resulting From Lease Renewals
RightOfUseAssetAdditionsResultingFromLeaseRenewals
7236663 usd
CY2022 us-gaap Stock Issued1
StockIssued1
0 usd
CY2021 us-gaap Stock Issued1
StockIssued1
12758473 usd
CY2022 cxxif Common Shares Issued In Settlement Of Earn Out Shares
CommonSharesIssuedInSettlementOfEarnOutShares
677939 usd
CY2021 cxxif Common Shares Issued In Settlement Of Earn Out Shares
CommonSharesIssuedInSettlementOfEarnOutShares
0 usd
CY2022 cxxif Common Shares Issued As Partial Settlement Of Commitment To Issue Shares
CommonSharesIssuedAsPartialSettlementOfCommitmentToIssueShares
21787 usd
CY2021 cxxif Common Shares Issued As Partial Settlement Of Commitment To Issue Shares
CommonSharesIssuedAsPartialSettlementOfCommitmentToIssueShares
450953 usd
CY2022 cxxif Common Shares Issued To Complete Purchase Of Land
CommonSharesIssuedToCompletePurchaseOfLand
0 usd
CY2021 cxxif Common Shares Issued To Complete Purchase Of Land
CommonSharesIssuedToCompletePurchaseOfLand
2582903 usd
CY2022 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2021 us-gaap Notes Issued1
NotesIssued1
38415 usd
CY2022Q1 us-gaap Cash
Cash
3067983 usd
CY2022Q1 cxxif Working Capital Deficit
WorkingCapitalDeficit
-4444076 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68510333 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="color: #1b968d;">Significant accounting estimates and assumptions</span></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of the Company's financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are continuously evaluated and are based on management's experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from those estimates and judgments.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Areas requiring a significant degree of estimation and judgment relate to the determination of fair values of assets acquired and liabilities assumed in business combinations, impairment of long-lived assets and inventory, fair value measurements, useful lives, depreciation and amortization of property, equipment and intangible assets, the recoverability and measurement of deferred tax assets and liabilities, share-based compensation, and fair value of derivative liabilities.</span></span></p> </div>
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5001360 usd
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5001360 usd
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2021 cxxif Right Of Use Asset Additions Resulting From Lease Renewals
RightOfUseAssetAdditionsResultingFromLeaseRenewals
7236663 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
461364 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
800269 usd
CY2022 cxxif Operating Lease Right Of Use Asset Amortization Expense Allocated To Inventory
OperatingLeaseRightOfUseAssetAmortizationExpenseAllocatedToInventory
265788 usd
CY2021 cxxif Operating Lease Right Of Use Asset Amortization Expense Allocated To Inventory
OperatingLeaseRightOfUseAssetAmortizationExpenseAllocatedToInventory
450413 usd
CY2022Q1 us-gaap Goodwill
Goodwill
28541323 usd
CY2021Q1 us-gaap Goodwill
Goodwill
28541323 usd
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5001360 usd
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5001360 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1403743 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1249422 usd
CY2022 cxxif Portion Of Operating Lease Costs Allocated To Inventory
PortionOfOperatingLeaseCostsAllocatedToInventory
812368 usd
CY2021 cxxif Portion Of Operating Lease Costs Allocated To Inventory
PortionOfOperatingLeaseCostsAllocatedToInventory
700185 usd
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y5M15D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y3M25D
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1239090 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1276263 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1314551 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1353987 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1394607 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
9148938 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15727436 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6448313 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
9279123 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
325698 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8953425 usd
CY2022Q1 cxxif Lease Liabilities Classified As Held For Sale
LeaseLiabilitiesClassifiedAsHeldForSale
412093 usd
CY2021Q1 cxxif Lease Liabilities Classified As Held For Sale
LeaseLiabilitiesClassifiedAsHeldForSale
1217499 usd
CY2022Q1 cxxif Undiscounted Lease Liabilities With Related Parties
UndiscountedLeaseLiabilitiesWithRelatedParties
16792993 usd
CY2022Q1 cxxif Undiscounted Lease Liabilities Classified As Held For Sale
UndiscountedLeaseLiabilitiesClassifiedAsHeldForSale
1065557 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3240000
CY2020Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
3850396 usd
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
130000 usd
CY2022 cxxif Number Of Shares Issued To Vendors
NumberOfSharesIssuedToVendors
2142000
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1905635 usd
CY2022Q1 cxxif Remaining Number Of Shares To Be Delivered
RemainingNumberOfSharesToBeDelivered
793093
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5694746
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.66
CY2020 cxxif Weighted Average Remaining Life Of Warrants Outstanding
WeightedAverageRemainingLifeOfWarrantsOutstanding
P0Y8M26D
CY2021 cxxif Number Of Warrants Issued
NumberOfWarrantsIssued
6200000
CY2021 cxxif Weighted Average Exercise Price Of Warrants Issued
WeightedAverageExercisePriceOfWarrantsIssued
1
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11894746
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.32
CY2021 cxxif Weighted Average Remaining Life Of Warrants Outstanding
WeightedAverageRemainingLifeOfWarrantsOutstanding
P1Y11M15D
CY2022 cxxif Number Of Warrants Exercised
NumberOfWarrantsExercised
4616100
CY2022 cxxif Weighted Average Exercise Price Of Warrants Exercised
WeightedAverageExercisePriceOfWarrantsExercised
1.05
CY2022 cxxif Number Of Warrants Expired
NumberOfWarrantsExpired
4038646
CY2022 cxxif Weighted Average Exercise Price Of Warrants Expired
WeightedAverageExercisePriceOfWarrantsExpired
1.73
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3240000
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.18
CY2022 cxxif Weighted Average Remaining Life Of Warrants Outstanding
WeightedAverageRemainingLifeOfWarrantsOutstanding
P2Y1M6D
CY2020Q2 cxxif Number Of Warrants Outstanding With Extended Expiry Date
NumberOfWarrantsOutstandingWithExtendedExpiryDate
2794746
CY2020Q2 cxxif Exercise Price Of Warrants Outstanding With Extended Expiry Date
ExercisePriceOfWarrantsOutstandingWithExtendedExpiryDate
1.83
CY2021Q1 cxxif Number Of Warrants Exercised
NumberOfWarrantsExercised
456100
CY2021Q1 cxxif Weighted Average Exercise Price Of Warrants Exercised
WeightedAverageExercisePriceOfWarrantsExercised
1.17
CY2021Q1 cxxif Weighted Average Exercise Price Of Warrants Exercised
WeightedAverageExercisePriceOfWarrantsExercised
1.5
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
456100
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
533326 usd
CY2021Q1 cxxif Number Of Warrants Expired
NumberOfWarrantsExpired
1243900
CY2021Q2 cxxif Number Of Warrants Exercised
NumberOfWarrantsExercised
4160000
CY2021Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1214080
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3255000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.78
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y2M4D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4055000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.73
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
200000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.65
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
145000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.71
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6965000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.22
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y18D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1350000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.8
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5615000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.84
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y5M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5615000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4263333
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
366469 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
494435 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0019 pure
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 cxxif Undiscounted Lease Payments Under Other Commitment
UndiscountedLeasePaymentsUnderOtherCommitment
456383 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3425756 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
547490 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3973246 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2968133 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17132041 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1633439 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.27 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-441029 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1530604 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1842777 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-602698 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-654621 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
737667 usd
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-919606 usd
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1431416 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3973246 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2968133 usd
CY2022Q1 cxxif Deferred Tax Assets Share Issuance Costs And Financing Fees
DeferredTaxAssetsShareIssuanceCostsAndFinancingFees
254662 usd
CY2022Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
140224 usd
CY2022Q1 cxxif Deferred Tax Assets Non Capital Losses
DeferredTaxAssetsNonCapitalLosses
4409825 usd
CY2022Q1 cxxif Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
940967 usd
CY2022Q1 cxxif Deferred Tax Assets Mineral Resource Properties
DeferredTaxAssetsMineralResourceProperties
0 usd
CY2021Q1 cxxif Deferred Tax Assets Mineral Resource Properties
DeferredTaxAssetsMineralResourceProperties
983977 usd
CY2022Q1 cxxif Deferred Tax Assets Rightof Use Assets And Lease Liabilities Net
DeferredTaxAssetsRightofUseAssetsAndLeaseLiabilitiesNet
98352 usd
CY2022Q1 cxxif Deferred Tax Assets Goodwill
DeferredTaxAssetsGoodwill
0 usd
CY2021Q1 cxxif Deferred Tax Assets Goodwill
DeferredTaxAssetsGoodwill
0 usd
CY2022Q1 cxxif Deferred Tax Assets Reclamation Obligation
DeferredTaxAssetsReclamationObligation
14923 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5858953 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4919214 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
939739 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
930715 usd
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
9024 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4919214 usd
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5573835 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
8172075 usd
CY2022Q1 cxxif Lease Liabilities Due To Company Controlled By Ceo
LeaseLiabilitiesDueToCompanyControlledByCeo
9279123 usd
CY2021Q1 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
14369004 usd
CY2021Q1 cxxif Lease Liabilities Due To Company Controlled By Ceo
LeaseLiabilitiesDueToCompanyControlledByCeo
9539744 usd
CY2022Q1 cxxif Lease Liabilities Due To Sdp Development
LeaseLiabilitiesDueToSdpDevelopment
412093 usd
CY2021Q1 cxxif Lease Liabilities Due To Sdp Development
LeaseLiabilitiesDueToSdpDevelopment
589328 usd
CY2022Q1 cxxif Due To Chief Financial Officer
DueToChiefFinancialOfficer
360 usd
CY2021Q1 cxxif Due To Chief Financial Officer
DueToChiefFinancialOfficer
527 usd
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
17863651 usd
CY2021Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
24498603 usd
CY2022 cxxif Amounts Paid To Ceo Or Companies Controlled By Ceo
AmountsPaidToCeoOrCompaniesControlledByCeo
8632619 usd
CY2021 cxxif Amounts Paid To Ceo Or Companies Controlled By Ceo
AmountsPaidToCeoOrCompaniesControlledByCeo
10368616 usd
CY2022 cxxif Convertible Debenture Interest Paid To Directors And Officers
ConvertibleDebentureInterestPaidToDirectorsAndOfficers
0 usd
CY2021 cxxif Convertible Debenture Interest Paid To Directors And Officers
ConvertibleDebentureInterestPaidToDirectorsAndOfficers
18346 usd
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9829935 usd
CY2021 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
11475474 usd
CY2022 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div> <p style="text-align: justify; margin-top: 10px;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22.<span style="display: inline-block; width: 4.5pt;"> </span>CONTINGENCIES</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">From time to time, the Company is involved in various litigation matters arising in the ordinary course of its business. Management is of the opinion that disposition of any current matter will not have a material adverse impact on the Company's balance sheet, results of operations, or the ability to carry on any of its business activities.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="color: #1b968d;">Legal proceedings </span></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Oregon Action:</b> A complaint was filed in the Oregon State Circuit Court for Clackamas County, on April 29, 2019, by two current owners of Proudest Monkey Holdings, LLC (the former sole member of EFF) (the "Plaintiffs"), alleging contract, employment, and statutory claims, alleging $612,500 in damages (as amended), against the Company, its wholly-owned subsidiaries 320204 US Holdings Corp, EFF, Swell Companies Limited, and Phantom Brands LLC, in addition to three directors, two officers, and one former employee (the "Oregon Action"). The Company and the other defendants wholly denied the allegations and claims made in the lawsuit and is defending the lawsuit. On June 21, 2019, the Company filed Oregon Rule of Civil Procedure ("ORCP") 21 motions to dismiss all of the Plaintiffs' claims against it, its wholly-owned subsidiaries, and other defendants; on May 6, 2020, the court granted the Company's ORCP 21 motion in its entirety to dismiss all of Plaintiffs' claims. The judgment of dismissal was entered by the Clackamas County court on or about October 14, 2020. On November 12, 2020, Plaintiffs filed a notice of appeal of the judgement of dismissal.</span></span></p> <div> </div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On October 22, 2020, the Company submitted a petition to recover the costs and attorney fees incurred by the Company as the prevailing party in the Oregon Action. On January 20, 2021, the Court ruled in the Company's favor, awarding the Company and its subsidiaries $68,195 in attorney's fees, $1,252 in costs, and a statutory prevailing party fee of $640, through a supplemental judgment. On March 3, 2021, Plaintiffs filed an amended notice of appeal from the supplemental judgement awarding attorney fees. </span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The parties have since briefed the appeal to the Oregon Court of Appeals and await a determination from the Court. It is too early to predict the resolution of the appeal.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>British Columbia Action:</b> On or about September 13, 2019, the Company delivered a notice to the above-mentioned Plaintiffs of alleged breach and default under the EFF purchase and sale agreement, due to alleged unlawful, intentional acts and material misrepresentations by the Plaintiffs before and after the completion of the purchase. As a result of such breach, the Company denied the Plaintiffs' tender of their share payment notes in connection with the agreement. On or about October 14, 2019, Proudest Monkey Holdings, LLC and one of its current owners, sued the Company in the Supreme Court of British Columbia to compel the issuance and delivery of the subject shares, including interests and costs (the "British Columbia Action"). </span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On November 8, 2019, the Company responded and counterclaimed for general, special and punitive damages, including interest and costs, related to breach of contract, repudiation of contract, breach of indemnity and fraudulent and negligent misrepresentation by the Plaintiffs. Plaintiffs filed a response to the Company's counterclaims on or about June 5, 2020, and the parties stipulated to a form of amended pleading which included the joinder of additional parties, an owner of Proudest Monkey Holdings, LLC and EFF, and additional contract and equitable claims and damages, partially duplicative to those alleged by the Plaintiffs in the Oregon lawsuit (breach of contract, indemnity, unjust enrichment and wrongful termination claims). Plaintiffs allege $2,774,176 in damages (as amended), plus unquantified additional damages, interest and costs, of which amounts are partially duplicative of the Oregon Action. This action remains in the discovery stage, but no trial date has been set. It is too early to predict the resolution of the claims and counterclaims.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Settled and Dismissed Action:</b> On or about May 30, 2019, Wallace Hill Partners Ltd. ("Wallace Hill") filed a civil claim in the Supreme Court of British Columbia alleging breach of contract and entitlement to 1,800,000 common shares of the Company, fully vested by March 1, 2019, and damages due to the lost opportunity to sell those shares after such date for a profit. On June 23, 2019, the Company circulated a letter to Wallace Hill terminating the agreement and accepting Wallace Hill's repudiation of the agreement based on Wallace Hill's previously published defamatory comments and termination of the agreement. Also, on June 23, 2019, the Company filed its response to the civil claim denying all claims and filed counterclaims alleging breach of contract, a declaratory judgment of termination of the agreement, defamation and an injunction from further defamatory comments.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On March 23, 2022, the Company and Wallace Hill entered into a mutual release agreement, pursuant to which, among other things, all parties agreed to dismiss their respective claims and to release one another from any further causes of action in connection with the subject matter of the original claims. On April 23, 2022, the parties filed a Notice of Discontinuance in the Supreme Court of British Columbia formally dismissing the civil action.</span></span></p> </div>

Files In Submission

Name View Source Status
0001062993-22-018015-index-headers.html Edgar Link pending
0001062993-22-018015-index.html Edgar Link pending
0001062993-22-018015.txt Edgar Link pending
0001062993-22-018015-xbrl.zip Edgar Link pending
cxxif-20220131.xsd Edgar Link pending
exhibit12-1.htm Edgar Link pending
exhibit12-2.htm Edgar Link pending
exhibit13-1.htm Edgar Link pending
exhibit13-2.htm Edgar Link pending
exhibit15-1.htm Edgar Link pending
exhibit15-1x001.jpg Edgar Link pending
exhibit15-3.htm Edgar Link pending
exhibit4-4.htm Edgar Link pending
exhibit4-5.htm Edgar Link pending
exhibit8-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form20f.htm Edgar Link pending
form20fxz001.jpg Edgar Link pending
form20fxz002.jpg Edgar Link pending
form20fxz003.jpg Edgar Link pending
form20fxz004.jpg Edgar Link pending
form20fxz005.jpg Edgar Link pending
form20fxz006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cxxif-20220131_def.xml Edgar Link unprocessable
cxxif-20220131_pre.xml Edgar Link unprocessable
cxxif-20220131_lab.xml Edgar Link unprocessable
form20f_htm.xml Edgar Link completed
cxxif-20220131_cal.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending